Paper Details

  1. Home
  2. Paper Details

Polypharmacy in Osteoporosis Treatment.

Author: McConnellMegan, ShiehAlbert

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study discusses the importance of individualized treatment selection for osteoporosis in older adults who are also taking multiple medications (polypharmacy). It was found that polypharmacy is a risk factor for hip and fall-related fractures, and the selection of osteoporosis treatment should consider individual factors such as fracture risk, comorbidities, medication burden, and side effects.
Paper Details　
Original Abstract of the Article :
In older adults, polypharmacy and osteoporosis frequently occur contemporaneously. Polypharmacy is increasingly recognized as a risk factor for hip and fall-related fractures. Treatments for osteoporosis include antiresorptive (alendronate, risedronate, zoledronic acid, ibandronate, denosumab) and o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.cger.2022.05.011

データ提供：米国国立医学図書館（NLM）

Polypharmacy in Osteoporosis: Navigating a Complex Desert Landscape

Polypharmacy, the use of multiple medications, is a common concern in older adults, particularly those with osteoporosis. This study explores the complex interplay between polypharmacy and osteoporosis treatment, highlighting the need for individualized care to balance fracture risk with medication burden. Imagine a vast desert landscape, where a delicate ecosystem exists, and a caravan of travelers (medications) needs to navigate this complex terrain to reach a destination (optimal health) while minimizing potential risks.

The authors discuss the challenges of polypharmacy in managing osteoporosis, emphasizing the importance of individualized treatment plans that consider various factors, including fracture risk, medical comorbidities, and medication burden. It's like navigating a desert with changing sand dunes and hidden pathways—careful planning and consideration are essential to ensure a safe and successful journey.

A Complex Desert: Balancing Fracture Risk and Medication Burden

This study highlights the importance of individualized treatment plans for osteoporosis, carefully considering both fracture risk and medication burden. It's like navigating a desert landscape with varying degrees of terrain—choosing the right path for each traveler can help to minimize risks and maximize success.

Navigating the Desert of Osteoporosis: Seeking Customized Solutions

The study emphasizes that managing osteoporosis requires a tailored approach that considers the unique needs and circumstances of each patient. It's a reminder that even in the seemingly vast and uniform desert of medical treatment, individualization is key to achieving optimal outcomes and ensuring a comfortable and successful journey through the landscape of healthcare.

Dr.Camel's Conclusion

This research underscores the importance of individualized care in managing complex conditions like osteoporosis, particularly in the context of polypharmacy. It's a reminder that even in the vast and complex desert of medicine, careful planning and attention to individual needs can lead to better outcomes and a more comfortable and fulfilling journey through the landscape of healthcare.

Date :
  1. Date Completed 2022-10-11
  2. Date Revised 2022-10-27
Further Info :

Pubmed ID

36210087

DOI: Digital Object Identifier

10.1016/j.cger.2022.05.011

Related Literature

Article Analysis
・Side Effects of risedronate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.